The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. PepGen's Revenue for the
three
months ended in Dec. 2024 was $0.00 Mil. PepGen's average Accounts Receivable for the
three
months ended in Dec. 2024 was $0.00 Mil.
PepGen Receivables Turnover Historical Data
The historical data trend for PepGen's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PepGen's Receivables Turnover
For the Biotechnology subindustry, PepGen's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PepGen's Receivables Turnover Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PepGen's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where PepGen's Receivables Turnover falls into.
PepGen Receivables Turnover Calculation
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
PepGen's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
PepGen Receivables Turnover Related Terms
Thank you for viewing the detailed overview of PepGen's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PEPG has been successfully added to your 